NanoString Takes Option to Liver Cancer Gene Signature for Possible Assay Development | GenomeWeb

NEW YORK (GenomeWeb News) – NanoString Technologies today announced it has secured the option to exclusively license a 186-gene signature from the Broad Institute that may be useful in determining the prognosis of patients diagnosed with hepatocellular carcinoma, or HCC.

In addition to potentially being useful for HCC, the gene signature may also help determine the prognosis of patients with hepatitis C-related early stage cirrhosis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

DNA Sequencing is being used by researchers in California to survey fish and marine life as part of a conservation effort.

This week in Nature: Researchers describe the adaptation of organisms to environmental changes, while another study provides new insights into pig domestication.

The blog Sartorial Science seeks to challenge the stereotype of scientists as frumpy, messy, clueless dressers.

While one researcher says cloning the mammoth may be decades away, if successful, it may lead to a theme park of species that would no longer be extinct.